6.
Multivariate Cox regression of risk factors associated with OS
| Covariables | Beta | SE | Wald | HR | 95% CI | P |
| OS, overall survival; LGG, low-grade glioma; HGG, high-grade glioma; IDH, isocitrate dehydrogenase; EGFRvIII, epidermal growth factor receptor variant III; SE, standard error; HR, hazard ratio; 95% CI, 95% confidence interval. | ||||||
| Chart 1 | ||||||
| Age (<50vs. ≥50 years) | 0.687 | 0.25 | 7.544 | 1.988 | 1.217−3.245 | 0.006 |
| Tumor grade (LGG vs. HGG) | 2.154 | 0.48 | 20.112 | 8.617 | 3.362−22.087 | <0.001 |
| 1p/19q codeletion (No vs. Yes) | −0.758 | 0.37 | 4.19 | 0.468 | 0.277−0.968 | 0.041 |
| IDH mutation (No vs. Yes) | −0.673 | 0.28 | 5.777 | 0.51 | 0.295−0.883 | 0.016 |
| EGFRvIII expression (Low vs. High) | −0.089 | 0.241 | 0.138 | 0.914 | 0.570−1.467 | 0.711 |
| Chart 2 | ||||||
| Age (<50vs. ≥50 years) | 0.55 | 0.242 | 5.179 | 1.733 | 1.079−2.781 | 0.023 |
| Tumor grade (LGG vs. HGG) | 2.076 | 0.477 | 18.901 | 7.972 | 3.127−20.324 | <0.001 |
| 1p/19q codeletion (No vs. Yes) | −0.861 | 0.37 | 5.421 | 0.423 | 0.205−0.873 | 0.020 |
| IDH mutation (No vs. Yes) | −0.553 | 0.278 | 3.973 | 0.575 | 0.334−0.991 | 0.046 |
| EGFRvIII nuclear translocation (<7%vs. ≥7%) | 0.653 | 0.228 | 8.191 | 1.920 | 1.228−3.003 | 0.004 |